Who
Elizabeth Hurlburt
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, CorMedix.
In numbers
- Trades disclosed
- 50
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $2.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Mar 2018
- Last trade
- 29 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Aug 2026filed 1 Sep 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $67K8,076 at $8.30 | filing |
| 29 Aug 2026filed 1 Sep 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $67K8,076 at $8.30 | filing |
| 4 Feb 2026filed 6 Feb 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —36,006 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —36,006 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —93,010 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $78K10,778 at $7.27 | filing |
| 23 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —93,010 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $78K10,778 at $7.27 | filing |
| 12 Jan 2026filed 20 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $41K5,794 at $7.15 | filing |
| 12 Jan 2026filed 20 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $41K5,794 at $7.15 | filing |
| 2 Jan 2026filed 6 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $132K10,895 at $12.16 | filing |
| 2 Jan 2026filed 6 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $132K10,895 at $12.16 | filing |
| 11 Sep 2025filed 11 Sep 2025 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —41,121 at $0.00 | filing |
| 11 Sep 2025filed 11 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code M | $60K41,121 at $1.45 | filing |
| 11 Sep 2025filed 11 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Sold | $538K41,121 at $13.08 | filing |
| 9 Sep 2025filed 11 Sep 2025 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —12,876 at $0.00 | filing |
| 9 Sep 2025filed 11 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code M | $19K12,876 at $1.45 | filing |
| 9 Sep 2025filed 11 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Sold | $174K12,876 at $13.51 | filing |
| 29 Aug 2025filed 8 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $125K8,424 at $14.83 | filing |
| 29 Aug 2025filed 3 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —69,686 at $0.00 | filing |
News
Head-To-Head Survey: Inhibikase Therapeutics (NASDAQ:IKT) versus CorMedix (NASDAQ:CRMD)CRMD · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Elizabeth Hurlburt; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.